By 2060, new dementia cases per year could double to one million because of the growing population of older Americans, a ...

Dementia cases in the U.S. are expected to double by 2060, with an estimated one million people diagnosed per year, according ...

LEXINGTON Researchers at the University of Kentucky’s Sanders-Brown Center on Aging are at the forefront of advancing ...

Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the ...

The evidence of gabapentin and dementia is mixed, with two studies looking at hundreds of thousands of people and coming to ...

A doctor who punched a dementia patient in the head and pushed his head into a pillow, has been erased from the medical ...

Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the ...

A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...

The FDA has accepted the BLA for lecanemab-irmb SC for weekly maintenance dosing in the treatment of early Alzheimer disease.

Leqembi's subcutaneous dosing allows Alzheimer's patients to administer weekly treatment at home in 15 seconds ... s disease ...

The FDA has accepted Eisai and Biogen’s biologics license application for a monthly infusion of IV Leqembi to treat ...